哪种政府补贴方式更能促进企业创新——基于医药制造业不同所有制企业PVAR动态效应的比较视角

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (6050 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract The paper studies dynamic interaction effect among different government subsidies,R&D investment and innovation performance,and the difference between state-owned enterprises and non-state-owned enterprises.On the basis of the panel data of different ownership pharmaceutical listed companies in China from 2008 to 2015 with PVAR model,the paper uses impulse response function and variance decomposition analysis methods.Results show that:①Compared with the supportive government subsidies,incentive government-subsidies can promote the enterprise's R&D investment and innovation performance greater;innovation performance promotes incentive government subsidies,while R&D investment inhibits incentive government subsidies.The interaction is more significant in state-owned enterprise.②The supportive government subsidies squeeze R&D investment but promote innovation performance;R&D investment promotes but innovation inhibits supportive government subsidies.The interaction is more significant in non-state-owned enterprises.③R&D investment and innovation performance promote each other,and the interaction is more significant in non-state-owned enterprises.

Key words： The way of government subsidy R&D investment Innovation performance Dynamic effects

Received: 28 April 2017

PACS:	F812.45
	F273.1
	F223

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Shang Hongtao
	Huang Xiaoshuo

Cite this article:

Shang Hongtao,Huang Xiaoshuo. Which Kind of Government Subsidies Will Promote Innovation More Effectively? ——Analysis on Different Ownership Enterprises by PVAR Model in Pharmaceutical Manufacturing Industry[J]. , 2018, 0(1): 58-67.

URL:

http://www.zgkjlt.org.cn/EN/ OR http://www.zgkjlt.org.cn/EN/Y2018/V0/I1/58

[1]孙早,宋炜.企业R&D投入对产业创新绩效的影响——来自中国制造业的经验证据[J].数量经济技术经济研究,2012(4):49-63.
[2]刘秉镰,徐锋,李兰冰.中国医药制造业创新效率评价与要素效率解构[J].管理世界,2013(2):169-171.
[3]郭研,郭迪,姜坤.政府资助、项目筛选和企业的创新产出——来自科技型中小企业创新基金的证据[J].产业经济研究,2015(2):33-46.
[4]ALECKE B,MITZE T,REINKOWSKI J,et al.Does firm size make a difference? Analysing the effectiveness of R&D subsidies in east germany[J].German economic review,2012,13(2):174-195.
[5]吕晓军.政府补贴与企业技术创新产出——来自2009—2013年战略性新兴产业上市公司的证据[J].中国科技论坛,2016(12):60-66.
[6]唐清泉.政府R&D资助,企业R&D支出与自主创新——来自中国上市公司的经验证据[J].金融研究,2009(6):86-99.
[7]白俊红,李婧.政府R&D资助与企业技术创新——基于效率视角的实证分析[J].金融研究,2011(6):181-193.
[8]李文秀,魏守道.研发形式与发展中国家实施研发补贴的效果[J].中国科技论坛,2017(1):186-192.
[9]LACH S.Do R＆D subsidies stimulate or displace private R&D Evidence from Israel[J].Journal of industrial economics,2002(4):369-390.
[10]GORG H,STROBL E.The effect of R&D subsidies on private R&D[J].Economica,2007(294):215-234.
[11]张春辉,陈继祥.两种创新补贴对创新模式选择影响的比较分析[J].科研管理,2011,32(8):9-16.
[12]生延超.创新投入补贴还是创新产品补贴:技术联盟的政府策略选择[J].中国管理科学,2008,16(6):184-192.
[13]刘楠,杜跃平.政府补贴方式选择对企业研发创新的激励效应研究[J].科技进步与对策,2005,22(11):18-19.
[14]马永红,那琪.产学研合作创新补贴方式研究:以欠发达地区企业为例[J].科技进步与对策,2016,33(1):38-44.
[15]张兴龙,沈坤荣,李萌.政府R&D补助方式如何影响企业R&D投入?——来自A股医药制造业上市公司的证据[J].产业经济研究,2014(5):53-62
[16]盛光华,张志远.补贴方式对创新模式选择影响的演化博弈研究[J].管理科学学报,2015,18(9):34-45.
[17]王宇,刘志彪.补贴方式与均衡发展:战略性新兴产业成长与传统产业调整[J].中国工业经济,2013(8):57-69.
[18]吴延兵.不同所有制企业技术创新能力考察[J].产业经济研究,2014(2):53-64.
[19]刘虹,肖美凤,唐清泉.R&D补贴对企业R&D支出的激励与挤出效应——基于中国上市公司数据的实证分析[J].经济管理,2012(4).
[20]肖文,林高榜.政府支持、研发管理与技术创新效率——基于中国工业行业的实证分析[J].管理世界,2014(4):71-80.
[21]杨洋,魏江,罗来军.谁在利用政府补贴进行创新?——所有制和要素市场扭曲的联合调节效应[J].管理世界,2015(1):75-86.
[22]冯根福,刘军虎,徐志霖.中国工业部门研发效率及其影响因素实证分析[J].中国工业经济,2006(11):46-51.
[23]陈玲,杨文辉.政府研发补贴会促进企业创新吗?——来自中国上市公司的实证研究[J].科学学研究,2016,34(3):433-442.
[24]沈弋,徐光华,钱明.双元创新动因、研发投入与企业绩效——基于产权异质性的比较视角[J].经济管理,2016(2):69-80.
[25]张瑞,苏方林,李臣.基于PVAR模型的R&D投入与产出关系的实证研究[J].科学学与科学技术管理,2011,32(12):18-25.
[26]赵喜仓,任洋.R&D投入、专利产出效率和经济增长实力的动态关系研究——基于江苏省13个地级市面板数据的PVAR分析[J].软科学,2014,28(10):18-21.
[27]陆国庆,王舟,张春宇.中国战略性新兴产业政府创新补贴的绩效研究[J].经济研究,2014,49(7):44-55.